Rupture of uterine muscle hematoma following diagnostic amniocentesis at 18 weeks and uterine dehiscence at term

Author(s):  
Zane Krastiņa ◽  
Jānis Šavlovskis ◽  
Anna Langrate ◽  
Toms Znotiņš

Uterine rupture during pregnancy is a rare complication that, like any rupture in other body organ, has a life-saving condition. However, in this case, it threatens both, the mother and the child lives and it can lead to serious complications such as asphyxia, hemorrhagic shock, perinatal hysterectomy, hypoxic ischemic encephalopathy, brain injury, and death. It is known, that most often, it develops during the third trimester of pregnancy or during labor. We report a patient who experienced uterine rupture with 2500 ml blood loss following the diagnostic amniocentesis at 16 weeks. The same patient had suture dehiscence at the site of hematoma what was revealed during the Caesarean section at 37 weeks and a healthy baby was delivered.

PEDIATRICS ◽  
1973 ◽  
Vol 52 (4) ◽  
pp. 494-503
Author(s):  
Richard L. Naeye ◽  
William Blanc ◽  
Cheryl Paul

In a study of 467 gestations maternal stature had little correlation with fetal growth but mother's pregravid body weight as well as weight gain and low-calorie diets during pregnancy did have such a correlation. Maternal undernutrition before the third trimester had little or no influence on fetal body, organ, and cellular growth while such effects were pronounced in late gestation. Fetal body and organ growth improved with successive pregnancies except in the most poorly nourished mothers, whose successive neonates became more growth retarded.


1991 ◽  
Vol 66 (6) ◽  
pp. 608-613 ◽  
Author(s):  
JO T. VAN WINTER ◽  
PAUL L. OGBURN ◽  
JUDITH A. NEY ◽  
DAVID J. HETZEL

2021 ◽  
Vol 2 (2) ◽  
pp. 51-56
Author(s):  
Sucu Roxana ◽  
Bordeianu Ion

Ultrasonographic evaluation of the hysterorrhaphy scar is an extremely important element in current obstetrical practice, especially in patients who still want a future pregnancy. The purpose of our study was to evaluate the ultrasound findings of the cesarean scar in the third trimester of pregnancy that can reduce the life-threatening emergencies caused by repeated cesarean section such as uterine rupture of abnormal placental adhesions. We conducted a prospective study that included patients who gave birth by caesarean section and presented at a subsequent pregnancy to be monitored during pregnancy. The study was realized during 2016-2020at the Bucur Maternity Hospital, 'Saint John', Bucharest.  A number of 57 patients were included in the analyzed group. A number of 12 pregnant women (21%) monitored both in weeks 30-34 and intraoperatively presented contractions and areas of dehiscence, while 30 (52.6%) pregnant women showed neither contractions nor areas of dehiscence. Women with contractions had an average scar thickness measured in the third trimester of 3.81 mm (SD 1.62, CI: [3.32; 4.30]), and those without contractions a thickness of 4.58 mm (SD 1.25, CI: [3.78; 5.37]. Intraoperatively we identified 3 cases with incomplete uterine rupture. Those cases were previously diagnosed with hysterorraphy scar between 0.15-0.5 cm. The repeated ultrasound evaluation of the cesarean scar is a good predictive factor for the intraoperative quality of the cesarean scar. With the third trimester ultrasound measurement of the uterine scar thickness, the uterine rupture may be avoided.


Author(s):  
Paul de Klaver ◽  
Carolien Geesink ◽  
Jasper Broen ◽  
Luc Derijks

Leflunomide is a prodrug for teruflunomide and used for rheumatic diseases. Teriflunomide is considered to be teratogenic and should be avoided in pregnancy. We describe a case of teriflunomide exposure up to the third trimester of pregnancy. A healthy baby was delivered, despite substantial drug exposure. Multiple washout procedures were required to reduce teriflunomide concentrations below the safe target concentration 0.02 mg/L.


Author(s):  
S. S. Subha ◽  
Mohana Dhanapal ◽  
Aiswary .

BACKGROUND:Neurosurgical disorders are a significant cause of non-obstetric death and disability in pregnant women. They pose a unique therapeutic challenge. The changes in normal physiology during pregnancy add to the complexity of management. The common conditions encountered are intracranial hemorrhage, tumours, trauma and spinal pathologies. It is preferrable to wait until the third trimester if the indication is semi-elective.MATERIALS AND METHODS: Here we present a prospective study of four cases , managed with neurosurgery in pregnancy and puerperium.RESULTS: Of the 4 cases two cases were craniotomy done for cortical vein thrombosis and two cases of excision of space occupying lesions.  CONCLUSIONS: Pregnancy itself should not be considered a contra-indication to neurosurgery, which when considered early in some patients, proves to be life-saving.


2013 ◽  
Vol 20 (3) ◽  
pp. 259-265
Author(s):  
Monica Vereş ◽  
Aurel Babeş ◽  
Szidonia Lacziko

Abstract Background and aims: Gestational diabetes represents a form of diabetes diagnosed during pregnancy that is not clearly overt diabetes. In the last trimester of gestation the growth of fetoplacental unit takes place, thus maternal hyperglycemia will determine an increased transplacental passage, hyperinsulinemia and fetal macrosomia. The aim of our study was that o analyzing the effect of maternal glycemia from the last trimester of pregnancy over fetal weight. Material and method: We run an observational study on a group of 46 pregnant women taken into evidence from the first trimester of pregnancy, separated in two groups according to blood glucose determined in the third trimester (before birth): group I normoglycemic and group II with hyperglycemia (>92mg/dl). Results: The mean value of third trimester glycemia for the entire group was of 87.13±22.03. The mean value of the glycemia determined in the third trimester of pregnancy was higher in the second group (109.17 mg/dl) in comparison to the first group (74.,21 mg/dl). The ROC curve for third trimester glycemia as fetal macrosomia appreciation test has an AUC of 0.517. Conclusions: Glycemia determined in the last trimester of pregnancy cannot be used alone as the predictive factor for fetal macrosomia.


Sign in / Sign up

Export Citation Format

Share Document